KRAS Mutation Analysis by PCR: A Comparison of Two Methods
2015
Background KRAS mutation assays are important companion diagnostic tests to guide anti-EGFR antibody treatment of metastatic colorectal cancer. Direct comparison of newer diagnostic methods with existing methods is an important part of validation of any new technique. In this this study, we have compared the Therascreen (Qiagen) ARMS assay with Competitive Allele-Specific TaqMan PCR (castPCR, Life Technologies) to determine equivalence for KRAS mutation analysis. Methods
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
17
Citations
NaN
KQI